Piper Sandler Companies (PIPR)
| Market Cap | 5.52B +23.3% |
| Revenue (ttm) | 2.02B +30.9% |
| Net Income | 281.66M +38.4% |
| EPS | 3.96 +38.5% |
| Shares Out | 71.04M |
| PE Ratio | 19.71 |
| Forward PE | 16.10 |
| Dividend | $2.05 (2.62%) |
| Ex-Dividend Date | May 29, 2026 |
| Volume | 157,974 |
| Open | 77.54 |
| Previous Close | 76.67 |
| Day's Range | 76.82 - 78.62 |
| 52-Week Range | 62.49 - 95.07 |
| Beta | 1.42 |
| Analysts | Buy |
| Price Target | 95.69 (+23.06%) |
| Earnings Date | May 1, 2026 |
About PIPR
Piper Sandler Companies operates as an investment bank and institutional securities firm that serves corporations, private equity groups, public entities, non-profit entities, and institutional investors in the United States and internationally. It offers investment banking services, institutional sales, and trading services for various equity and fixed income products; research services; advisory services, such as mergers and acquisitions, equity and debt financings, equity and debt private placements, debt capital markets advisory, restructur... [Read more]
Financial Performance
In 2025, Piper Sandler Companies's revenue was $1.90 billion, an increase of 24.47% compared to the previous year's $1.53 billion. Earnings were $281.33 million, an increase of 55.33%.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for PIPR stock is "Buy." The 12-month stock price target is $95.69, which is an increase of 23.06% from the latest price.
News
Piper Sandler Companies Slides: Investor presentation
Piper Sandler Companies has posted slides in relation to its latest quarterly earnings report, which was published on June 4, 2026.
CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus
Financing led by Piper Sandler Merchant Banking, with participation from new investors Johnson & Johnson Innovation – JJDC, Inc., Johnson & Johnson's corporate venture capital arm, and Medtronic Parti...
Piper Sandler Appoints New Co-Heads of Services and Industrials Investment Banking and Enhances Focus on Private Equity Advisory Business
MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, has named Rob Parker and Tripp Griffin as co-heads of services and industrials investment banking. Matt S...
Piper Sandler (PIPR) Says Strait of Hormuz Likely to Remain Closed for Months
Gas prices are likely to move even higher this summer.
Piper Sandler Companies Transcript: AGM 2026
The meeting covered board introductions, director elections, auditor ratification, and an advisory vote on executive compensation. All proposals passed with strong shareholder support, and no additional questions were raised.
Piper Sandler adds distressed debt, special asset group to Fixed Income platform
Piper Sandler (PIPR) Companies announced the additions of John Mori and Eric Friel as managing directors to lead a new group that will focus on distressed debt and special assets.
Piper Sandler Strengthens Fixed Income Platform with the Addition of Distressed Debt and Special Asset Group
NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of John Mori and Eric Friel as managing directors to lead a new group t...
Piper Sandler Companies Slides: Investor presentation
Piper Sandler Companies has posted slides in relation to its latest quarterly earnings report, which was published on May 4, 2026.
Piper Sandler Companies Earnings Call Transcript: Q1 2026
Q1 2026 saw strong year-over-year growth in revenues and margins, led by record results in healthcare and investment banking. Advisory and financing pipelines remain robust, but Q2 revenues are expected to be flat or down in several segments due to market volatility and macro uncertainty.
Piper Sandler Companies Earnings release: Q1 2026
Piper Sandler Companies released its Q1 2026 earnings on May 1, 2026, summarizing the period's financial results.
Piper Sandler Companies Quarterly report: Q1 2026
Piper Sandler Companies has published its Q1 2026 quarterly earnings report on May 1, 2026.
Piper Sandler Companies Reports First Quarter 2026 Results; Increases Quarterly Dividend to $0.20 Per Share
MINNEAPOLIS--(BUSINESS WIRE)---- $PIPR--The complete earnings release can be found on the firm's website at pipersandler.com/earnings.
Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Patrick McCormack
MINNEAPOLIS & SAN FRANCISCO--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Patrick McCormack, M.D. as a managing director in ...
Piper Sandler Companies to Announce First Quarter 2026 Financial Results and Host a Conference Call on May 1, 2026
MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, will release its first quarter 2026 financial results prior to the opening of the market on Friday, May 1...
Piper Sandler price target raised to $97 from $88 at Goldman Sachs
Goldman Sachs analyst James Yaro raised the firm’s price target on Piper Sandler (PIPR) to $97 from $88 and keeps a Buy rating on the shares. Earnings estimates and price…
Piper Sandler Companies Proxy statement: Proxy filing
Piper Sandler Companies filed a proxy statement on April 9, 2026, providing details for shareholder voting and corporate governance matters.
Piper Sandler Companies Proxy statement: Proxy filing
Piper Sandler Companies filed a proxy statement on April 9, 2026, providing details for shareholder voting and corporate governance matters.
Piper Sandler Companies Proxy statement: Proxy filing
Piper Sandler Companies filed a proxy statement on April 9, 2026, providing details for shareholder voting and corporate governance matters.
Piper Sandler price target lowered to $88 from $98 at Goldman Sachs
Goldman Sachs analyst James Yaro lowered the firm’s price target on Piper Sandler (PIPR) to $88 from $98 and keeps a Buy rating on the shares. Piper Sandler offers idiosyncratic…
Piper Sandler price target lowered to $392 from $461 at Goldman Sachs
Goldman Sachs lowered the firm’s price target on Piper Sandler (PIPR) to $392 from $461 and keeps a Buy rating on the shares. Investment banking volumes are up 4% year…
Piper Sandler upgraded to Outperform from Market Perform at Northland
Northland upgraded Piper Sandler (PIPR) to Outperform from Market Perform with a $350 price target The firm believes the company’s advisory business has hit an “inflection point” that warrant a…
Piper Sandler Appoints Aamer Naseer to Head of Life Sciences Outsourcing and B2B Med Tech
MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the appointment of Aamer Naseer to global head of life sciences outsourcing and B2...
Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Jason Arnold
MINNEAPOLIS & LONDON--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Jason Arnold as a managing director in the healthcare inv...
Piper Sandler price target raised to $395 from $385 at BofA
BofA raised the firm’s price target on Piper Sandler (PIPR) to $395 from $385 and keeps an Underperform rating on the shares. Piper Sandler outperformed peers after reporting Q4 results,…
Piper Sandler Companies Earnings Call Transcript: Q4 2025
Record 2025 results with 22% revenue growth, strong advisory and financing performance, and robust capital returns. Outlook for 2026 remains positive with healthy pipelines, continued investments, and a 4-for-1 stock split to boost liquidity.